TITLE

Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities

AUTHOR(S)
Calzavara, Liviana; Ramuscak, Nancy; Burchell, Ann N.; Swantee, Carol; Myers, Ted; Ford, Peter; Fearon, Margaret; Raymond, Sue
PUB. DATE
July 2007
SOURCE
CMAJ: Canadian Medical Association Journal;7/31/2007, Vol. 177 Issue 3, p257
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Each year more than 56 000 adult and young offenders are admitted to Ontario's remand facilities (jails, detention centres and youth centres). The prevalence of HIV infection in Ontario remand facilities was last measured over a decade ago, and no research on the prevalence of hepatitis C virus (HCV) infection has been conducted in such facilities. We sought to determine the prevalence of HIV infection, HCV infection and HIV-HCV coinfection among inmates in Ontario's remand facilities. Methods: A voluntary and anonymous cross-sectional prevalence study of HIV and HCV infections was conducted among people admitted to 13 selected remand facilities across Ontario between Feb. 1, 2003, and June 20, 2004. Data collection included a saliva specimen for HIV and HCV antibody screening and an interviewer-administered survey. Prevalence rates and 95% confidence intervals were calculated and examined according to demographic characteristics, region of incarceration and self-reported history of injection drug use. Results: In total, 1877 participants provided both a saliva specimen and survey information. Among the adult participants, the prevalence of HIV infection was 2.1% among men and 1.8% among women. Adult offenders most likely to have HIV infection were older offenders (30 years) and injection drug users. The prevalence of HCV infection was 15.9% among men, 30.2% among women and 54.7% among injection drug users. Adult offenders most likely to have HCV infection were women, older offenders (≥30 years) and injection drug users. The prevalence of HCV-HIV coinfection was 1.2% among men and 1.5% among women. It was highest among older inmates and injection drug users. Among the young offenders, none was HIV positive and 1 (0.4%) was HCV positive. On the basis of the study results, we estimated that 1079 HIV-positive adults and 9208 HCV-positive adults were admitted to remand facilities in Ontario from Apr. 1, 2003, to Mar. 31, 2004. Interpretation: Adult offenders entering Ontario remand facilities have a considerably higher prevalence of HIV and HCV infections than the general population.
ACCESSION #
25809245

 

Related Articles

  • Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons. Poulin, Céline; Alary, Michel; Lambert, Gilles; Godin, Gaston; Landry, Suzanne; Gagnon, Hélène; Demers, Éric; Morarescu, Elena; Rochefort, Jean; Claessens, Christiane // CMAJ: Canadian Medical Association Journal;7/31/2007, Vol. 177 Issue 3, p252 

    Background: To determine the prevalence of HIV and hepatitis C virus (HCV) infections and examine risk factors for these infections among inmates in Quebec provincial prisons. Methods: Anonymous cross-sectional data were collected from January to June 2003 for men (n = 1357) and women (n = 250)...

  • Treatment of acute hepatitis C in HIV infection. Vogel, Martin; Rockstroh, Jürgen K. // Journal of Antimicrobial Chemotherapy (JAC);Jan2010, Vol. 65 Issue 1, p4 

    Within Europe and recently in the USA and Australia an ongoing epidemic of acute hepatitis C virus (HCV) infections among HIV-positive individuals, mainly men who have sex with men, has been observed. Other concomitant sexually transmitted diseases and sexual practices with a high risk of...

  • Within-host and between-host evolutionary rates across the HIV-1 genome. Alizon, Samuel; Fraser, Christophe // Retrovirology;2013, Vol. 10 Issue 1, p1 

    Background: HIV evolves rapidly at the epidemiological level but also at the within-host level. The virus' within-host evolutionary rates have been argued to be much higher than its between-host evolutionary rates. However, this conclusion relies on analyses of a short portion of the virus...

  • Treatment of hepatitis C in HIV-infected patients: significant progress but not the final step. Manns, Michael P.; Wedemeyer, Heiner // JAMA: Journal of the American Medical Association;12/15/2004, Vol. 292 Issue 23, p2909 

    Reports that hepatitis C virus (HCV) has become a major cause of morbidity and death in human immunodeficiency virus (HIV) infection. Statistics; Use of antiretroviral therapy to treat HCV; Reasons why the interactions between HCV and HIV are difficult to investigate; Treatment options; Risks...

  • Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons. Poulin, Céline; Alary, Michel; Lambert, Gilles; Godin, Gaston; Landry, Suzanne; Gagnon, Hélène; Demers, Éric; Morarescu, Elena; Rochefort, Jean; Claessens, Christiane // CMAJ: Canadian Medical Association Journal Supplement;7/31/2007, Vol. 177 Issue 3, p252 

    Background: To determine the prevalence of HIV and hepatitis C virus (HCV) infections and examine risk factors for these infections among inmates in Quebec provincial prisons. Methods: Anonymous cross-sectional data were collected from January to June 2003 for men (n= 1357) and women (n= 250)...

  • Deadly disregard: government refusal to implement evidence-based measures to prevent HIV and hepatitis C virus infections in prisons. Elliott, Richard // CMAJ: Canadian Medical Association Journal Supplement;7/31/2007, Vol. 177 Issue 3, p262 

    The author comments on two studies published within the issue on the prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities and among inmates of Quebec provincial prisons. He references findings from other related studies. He ponders on the actions taken by...

  • Molecular Mechanism of Hepatic Injury in Coinfection with Hepatitis C Virus and HIV. Balasubramanian, Anuradha; Koziel, Margaret; Groopman, Jerome E.; Ganju, Ramesli K. // Clinical Infectious Diseases;7/1/2005 Supplement, Vol. 41, pS32 

    We have previously shown that hepatocytes exposed to hepatitis C virus (HCV) and human immunodeficiency virus (HIV) envelope proteins undergo apoptosis. In this article, we further elucidate the signaling mechanisms that mediate this effect. We found that, in human hepatocellular carcinoma...

  • Neuropsychological Aspects of Coinfection with HIV and Hepatitis C Virus. Hilsabeck, Robin C.; Castellon, Steven A.; Hinkin, Charles H. // Clinical Infectious Diseases;7/1/2005 Supplement, Vol. 41, pS38 

    Infection with hepatitis C virus (HCV) is commonly seen in persons with human immunodeficiency virus (H IV) infection, because the viruses share risk factors for transmission; coinfection is a leading cause of morbidity and mortality among HIV-infected persons. Neuropsychological consequences of...

  • Investigating Neurocognitive Features of Hepatitis C Virus Infection in Drug Users: Potential Challenges and Lessons Learned from the HIV Literature. Gonzalez, Raul; Jacobus, Joanna; Martin, Eileen M. // Clinical Infectious Diseases;7/1/2005 Supplement, Vol. 41, pS45 

    Studies of neuro cognition in drug users with hepatitis C virus (HCV) infection are urgently needed but face many challenges. We review similarities between human immunodeficiency virus (H IV) and HCV infection in their neurocognitive features, discuss challenges associated with research among...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics